Invivyd IVVD
NASDAQ IVVD
$0.60 +0.02 (+4.01%)
As of: Nov 11, 2026 · 3:59 PM EST

Invivyd (IVVD) Capital Expenditures (2021 - 2026)

Updated

Analysis

Invivyd (IVVD) Capital Expenditures (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Invivyd 168.01 Mn -487.88 Mn 13.01 Mn 510,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 510,000.00
Mar 31, 2026 726,000.00
Jun 30, 2025 11,000.00
Mar 31, 2025 144,000.00
Dec 31, 2024 -5,000.00
Sep 30, 2024 5,000.00
Mar 31, 2024 140,000.00
Jun 30, 2023 -9,000.00
Mar 31, 2023 624,000.00
Dec 31, 2022 1.21 Mn
Sep 30, 2022 477,000.00
Jun 30, 2022 17,000.00
Dec 31, 2021 84,000.00
API Access

Invivyd Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IVVD&period=max&api_key=YOUR_API_KEY